- Home
- IMNN vs JYD Comparison
IMNN vs JYD Comparison
Compare IMNN & JYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMNN | JYD |
|---|---|---|
| Founded | 1982 | 2001 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9M | 7.2M |
| IPO Year | 2000 | 2022 |
Fundamental Metrics
Financial Performance| Metric | IMNN | JYD |
|---|---|---|
| Price | $1.04 | $0.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 155.3K | 37.9K |
| Earning Date | 11-12-2026 | 10-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.03 | $0.47 |
| 52 Week High | $5.29 | $6.85 |
Technical Indicators
Market Signals| Indicator | IMNN | JYD |
|---|---|---|
| Relative Strength Index (RSI) | 25.66 | 56.02 |
| Support Level | N/A | $0.67 |
| Resistance Level | $1.59 | $1.06 |
| Average True Range (ATR) | 0.12 | 0.10 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 15.87 | 71.10 |
Price Performance
Historical ComparisonAbout IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.
About JYD Jayud Global Logistics Limited
Jayud Global Logistics Ltd is an end-to-end supply chain solution provider in China, with a focus on providing cross-border logistics services. The company offers freight forwarding services, fragmented logistics, and chartered airline freight services, supply chain management, and other value-added services.